5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-(4-methoxypyrazol-1-yl)pyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-(1-methylpyrazol-4-yl)oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[(5-methyl-1H-pyrazol-4-yl)oxy]pyrazin-2-amine

C81H97N25O4 — CID 167624508

IUPAC5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-(4-methoxypyrazol-1-yl)pyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-(1-methylpyrazol-4-yl)oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[(5-methyl-1H-pyrazol-4-yl)oxy]pyrazin-2-amine
SMILESCOc1cnn(-c2nc(-c3cc(C)c4c(c3)CN(C)CC4)cnc2N)c1.Cc1cc(-c2cnc(N)c(Oc3cn[nH]c3C)n2)cc2c1CCN(C)C2.Cc1cc(-c2cnc(N)c(Oc3cnn(C)c3)n2)cc2c1CCN(C)C2.Cc1cc(-c2cnc(N)c(Oc3cnn(C4CCN(C)CC4)c3)n2)cc2c1CCN(C)C2
InChIInChI=1S/C24H31N7O.3C19H22N6O/c1-16-10-17(11-18-14-30(3)9-6-21(16)18)22-13-26-23(25)24(28-22)32-20-12-27-31(15-20)19-4-7-29(2)8-5-19;1-12-6-13(7-14-10-24(2)5-4-16(12)14)17-9-21-18(20)19(23-17)25-11-15(26-3)8-22-25;1-12-6-13(7-14-10-24(2)5-4-16(12)14)17-9-21-18(20)19(23-17)26-15-8-22-25(3)11-15;1-11-6-13(7-14-10-25(3)5-4-15(11)14)16-8-21-18(20)19(23-16)26-17-9-22-24-12(17)2/h10-13,15,19H,4-9,14H2,1-3H3,(H2,25,26);2*6-9,11H,4-5,10H2,1-3H3,(H2,20,21);6-9H,4-5,10H2,1-3H3,(H2,20,21)(H,22,24)
InChIKeyMXEYSOKXPJWEIT-UHFFFAOYSA-N
MW1484.84 g/mol
LogP10.89
Rot. Bonds13

About 5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-(4-methoxypyrazol-1-yl)pyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-(1-methylpyrazol-4-yl)oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[(5-methyl-1H-pyrazol-4-yl)oxy]pyrazin-2-amine

5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-(4-methoxypyrazol-1-yl)pyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-(1-methylpyrazol-4-yl)oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[(5-methyl-1H-pyrazol-4-yl)oxy]pyrazin-2-amine (PubChem CID 167624508) has the molecular formula C81H97N25O4 and a molecular weight of 1484.84 g/mol. Its IUPAC name is 5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-(4-methoxypyrazol-1-yl)pyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-(1-methylpyrazol-4-yl)oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[(5-methyl-1H-pyrazol-4-yl)oxy]pyrazin-2-amine.

Molecular Properties

Compound Name5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-(4-methoxypyrazol-1-yl)pyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-(1-methylpyrazol-4-yl)oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[(5-methyl-1H-pyrazol-4-yl)oxy]pyrazin-2-amine
PubChem CID167624508
Molecular FormulaC81H97N25O4
Molecular Weight1484.84 g/mol
Exact Mass1483.82
IUPAC Name5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-(4-methoxypyrazol-1-yl)pyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-(1-methylpyrazol-4-yl)oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[(5-methyl-1H-pyrazol-4-yl)oxy]pyrazin-2-amine
SMILESCOc1cnn(-c2nc(-c3cc(C)c4c(c3)CN(C)CC4)cnc2N)c1.Cc1cc(-c2cnc(N)c(Oc3cn[nH]c3C)n2)cc2c1CCN(C)C2.Cc1cc(-c2cnc(N)c(Oc3cnn(C)c3)n2)cc2c1CCN(C)C2.Cc1cc(-c2cnc(N)c(Oc3cnn(C4CCN(C)CC4)c3)n2)cc2c1CCN(C)C2
InChIInChI=1S/C24H31N7O.3C19H22N6O/c1-16-10-17(11-18-14-30(3)9-6-21(16)18)22-13-26-23(25)24(28-22)32-20-12-27-31(15-20)19-4-7-29(2)8-5-19;1-12-6-13(7-14-10-24(2)5-4-16(12)14)17-9-21-18(20)19(23-17)25-11-15(26-3)8-22-25;1-12-6-13(7-14-10-24(2)5-4-16(12)14)17-9-21-18(20)19(23-17)26-15-8-22-25(3)11-15;1-11-6-13(7-14-10-25(3)5-4-15(11)14)16-8-21-18(20)19(23-16)26-17-9-22-24-12(17)2/h10-13,15,19H,4-9,14H2,1-3H3,(H2,25,26);2*6-9,11H,4-5,10H2,1-3H3,(H2,20,21);6-9H,4-5,10H2,1-3H3,(H2,20,21)(H,22,24)
InChIKeyMXEYSOKXPJWEIT-UHFFFAOYSA-N
XLogP10.89
TPSA342.46 Ų
H-Bond Donors5
H-Bond Acceptors28
Rotatable Bonds13
Heavy Atoms110
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001484.84
LogP ≤ 510.89
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1028

Analyze 5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-(4-methoxypyrazol-1-yl)pyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-(1-methylpyrazol-4-yl)oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[(5-methyl-1H-pyrazol-4-yl)oxy]pyrazin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-(4-methoxypyrazol-1-yl)pyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-(1-methylpyrazol-4-yl)oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[(5-methyl-1H-pyrazol-4-yl)oxy]pyrazin-2-amine?
The IUPAC name of 5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-(4-methoxypyrazol-1-yl)pyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-(1-methylpyrazol-4-yl)oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[(5-methyl-1H-pyrazol-4-yl)oxy]pyrazin-2-amine (CID 167624508) is 5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-(4-methoxypyrazol-1-yl)pyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-(1-methylpyrazol-4-yl)oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[(5-methyl-1H-pyrazol-4-yl)oxy]pyrazin-2-amine.
What is the SMILES notation for 5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-(4-methoxypyrazol-1-yl)pyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-(1-methylpyrazol-4-yl)oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[(5-methyl-1H-pyrazol-4-yl)oxy]pyrazin-2-amine?
The canonical SMILES for 5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-(4-methoxypyrazol-1-yl)pyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-(1-methylpyrazol-4-yl)oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[(5-methyl-1H-pyrazol-4-yl)oxy]pyrazin-2-amine is COc1cnn(-c2nc(-c3cc(C)c4c(c3)CN(C)CC4)cnc2N)c1.Cc1cc(-c2cnc(N)c(Oc3cn[nH]c3C)n2)cc2c1CCN(C)C2.Cc1cc(-c2cnc(N)c(Oc3cnn(C)c3)n2)cc2c1CCN(C)C2.Cc1cc(-c2cnc(N)c(Oc3cnn(C4CCN(C)CC4)c3)n2)cc2c1CCN(C)C2.
What is the InChIKey of 5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-(4-methoxypyrazol-1-yl)pyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-(1-methylpyrazol-4-yl)oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[(5-methyl-1H-pyrazol-4-yl)oxy]pyrazin-2-amine?
The InChIKey is MXEYSOKXPJWEIT-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H31N7O.3C19H22N6O/c1-16-10-17(11-18-14-30(3)9-6-21(16)18)22-13-26-23(25)24(28-22)32-20-12-27-31(15-20)19-4-7-29(2)8-5-19;1-12-6-13(7-14-10-24(2)5-4-16(12)14)17-9-21-18(20)19(23-17)25-11-15(26-3)8-22-25;1-12-6-13(7-14-10-24(2)5-4-16(12)14)17-9-21-18(20)19(23-17)26-15-8-22-25(3)11-15;1-11-6-13(7-14-10-25(3)5-4-15(11)14)16-8-21-18(20)19(23-16)26-17-9-22-24-12(17)2/h10-13,15,19H,4-9,14H2,1-3H3,(H2,25,26);2*6-9,11H,4-5,10H2,1-3H3,(H2,20,21);6-9H,4-5,10H2,1-3H3,(H2,20,21)(H,22,24).
What are the key properties of 5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-(4-methoxypyrazol-1-yl)pyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-(1-methylpyrazol-4-yl)oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[(5-methyl-1H-pyrazol-4-yl)oxy]pyrazin-2-amine?
5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-(4-methoxypyrazol-1-yl)pyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-(1-methylpyrazol-4-yl)oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[(5-methyl-1H-pyrazol-4-yl)oxy]pyrazin-2-amine has a molecular weight of 1484.84 g/mol, XLogP of 10.89, 13 rotatable bonds, 5 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for 5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-(4-methoxypyrazol-1-yl)pyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-(1-methylpyrazol-4-yl)oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[(5-methyl-1H-pyrazol-4-yl)oxy]pyrazin-2-amine is sourced from PubChem (CID 167624508), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).